PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 80 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,305 | -34.1% | 7,744 | -9.1% | 0.05% | -31.9% |
| Q2 2023 | $121,935 | -34.8% | 8,515 | -49.5% | 0.07% | -4.0% |
| Q3 2022 | $187,000 | +32.6% | 16,847 | +0.7% | 0.08% | +44.2% |
| Q2 2022 | $141,000 | +20.5% | 16,726 | +95.1% | 0.05% | 0.0% |
| Q1 2022 | $117,000 | -34.6% | 8,575 | -5.6% | 0.05% | -23.5% |
| Q4 2021 | $179,000 | -9.1% | 9,080 | +47.6% | 0.07% | -21.8% |
| Q3 2021 | $197,000 | -10.0% | 6,150 | -5.0% | 0.09% | -3.3% |
| Q2 2021 | $219,000 | -13.8% | 6,476 | -4.1% | 0.09% | -15.9% |
| Q1 2021 | $254,000 | +15.5% | 6,753 | +1.8% | 0.11% | +17.6% |
| Q4 2020 | $220,000 | -3.9% | 6,635 | +6.3% | 0.09% | -24.2% |
| Q3 2020 | $229,000 | -1.7% | 6,242 | -11.8% | 0.12% | +9.1% |
| Q2 2020 | $233,000 | – | 7,076 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
| Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
| Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
| Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
| Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
| Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
| StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
| MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
| NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |